INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
SASHA LATYPOVA CALLS FOR EMA STAFF TO DO THE RIGHT THING
Copy link
Facebook
Email
Notes
More

SASHA LATYPOVA CALLS FOR EMA STAFF TO DO THE RIGHT THING

Hedley interviews Sasha, a pharma insider and whistleblower

Hedley Rees's avatar
Hedley Rees
Feb 24, 2022
∙ Paid
13

Share this post

INSIDE PHARMA
INSIDE PHARMA
SASHA LATYPOVA CALLS FOR EMA STAFF TO DO THE RIGHT THING
Copy link
Facebook
Email
Notes
More
5
Share

WHO IS SASHA LATYPOVA?

Sasha Latypova built two businesses in pharma over 20+ years, supporting companies like Pfizer and J&J in running clinical trials. She sold both businesses, and in 2014, retired to spend more time on the ski slopes.

Fast-forward to 2020, and SARS-CoV-2 drags her back into an industry she thought she had waved goodbye to forever. Thank heavens she returned, as this chilling interview demonstrates.

TOXIC BATCHES WERE FIRST ON THE LIST

It began with analysis of data recorded in the US Vaccine Adverse Event Reporting System (VAERS). Analysis was pointing towards some batches of injections that were far more toxic than the others. Sasha began collaborating with the analysts in the PJH Law team, with stunning results you can hear about in the interview.

This is where I happened upon Sasha’s work.

REGULATORY EVALUATION RAISES GIANT RED FLAG

Drilling down further into the global regulatory evaluation of emergency and conditional use applications, she was horrified at what she …

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More